Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-018205
Filing Date
2025-06-25
Accepted
2025-06-25 17:15:54
Documents
2
Period of Report
2025-06-23

Document Format Files

Seq Description Document Type Size
1 form3-06252025_090650.html 3  
1 form3-06252025_090650.xml 3 1694
2 ex24-06252025_090651.htm EX-24 10988
  Complete submission text file 0001415889-25-018205.txt   14371
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 343 ALLERTON AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Cote Elissa S. (Reporting) CIK: 0002069951 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37761 | Film No.: 251074489